Table 3.
Annual percentage change (APC) in age-adjusted incidence rates (number of breast cancer cases per 100,000 population) in women in 2000–2018 by hormone receptor status and race/ethnicity
| Race/Ethnicity | Hormone-receptor positive | Hormone-receptor negative | Hormone-receptor status unknown or borderline | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N. Cases | Incidence rate (95% CI) | APC (95% CI) from 2000 to 2018 | N. Cases | Incidence rate (95% CI) | APC (95% CI) from 2000 to 2018 | N. Cases | Incidence rate (95% CI) | APC (95% CI) from 2000 to 2018 | |
| Non-Hispanic Asians and Pacific Islanders | 66,990 | 109.5 (108.7, 110.4) | 2.5 (2.2, 2.7) | 13,786 | 22.3 (21.9, 22.7) | −0.6 (−1.1, 0.0) | 5,685 | 9.4 (9.2, 9.7) | −10.5 (−11.8, −9.1) |
| Non-Hispanic white | 620,197 | 146.6 (146.2, 147.0) | 1.4 (1.2, 1.7) | 113,751 | 28.0 (27.9, 28.2) | −1.3 (−1.9, −0.7) | 68,842 | 15.8 (15.6, 15.9) | −12.7 (−13.8, −11.6) |
| Non-Hispanic black | 75,918 | 114.1 (113.3, 115.0) | 2.8 (2.3, 3.3) | 31,706 | 46.5 (46.0, 47.1) | −0.3 (−1.0, 0.4) | 11,551 | 17.7 (17.4, 18.1) | −11.9 (−13.0, −10.8) |
| American Indians and Alaska Natives | 4,474 | 96.5 (93.5, 99.5) | 3.0 (2.2, 3.8) | 1,004 | 21.9 (20.5, 23.3) | −0.3 (−1.7, 1.1) | 451 | 10.5 (9.5, 11.5) | −6.3 (−8.6, −4.0) |
| Hispanics | 83,682 | 97.7 (97.0, 98.4) | 2.2 (1.9, 2.6) | 21,316 | 23.3 (22.9, 23.6) | −0.8 (−1.6, −0.1) | 10,311 | 12.3 (12.1, 12.6) | −10.1 (−11.5, −8.6) |
| Total | 851,161 | 133.1 (132.8,133.4) | 1.5 (1.2, 1.7) | 181,563 | 28.8 (28.7, 28.9) | −1.1 (−1.6, −0.5) | 96,840 | 15.0 (14.9, 15.1) | −12.1 (−13.3, −10.9) |
*
Incidence rates were age adjusted to the 2000 US population. Hormone-receptor positive was defined as estrogen-receptor was positive OR progesterone receptor was positive.